Dietary antioxidant compounds and liver health

Critical Reviews in Food Science and Nutrition

Volumn 44, Issue 7-8, 2004, Pages 575-586

  Vitaglione, Paola ^a   Morisco, Filomena ^a   Caporaso, Nicola ^a   Fogliano, Vincenzo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Tocopherol; Antioxidants; Carotenoids; Liver; Phenolic compounds; Resveratrol

Indexed keywords

Α-TOCOPHEROL; CAROTENOIDS; LIVER; RESVERATROL;

BODY FLUIDS; FRUIT JUICES; MOLECULAR DYNAMICS; NUTRITION; PATHOLOGY; PHENOLS; PROTEINS;

ANTIOXIDANTS;

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; FLAVONOID; LYCOPENE; PHENOL DERIVATIVE; POLYPHENOLS; QUERCETIN; RESVERATROL; RETINOL; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; BIOAVAILABILITY; DIET; HEALTH PROMOTION; HUMAN; LIVER; LIVER DISEASE; METABOLISM;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; BETA CAROTENE; BIOLOGICAL AVAILABILITY; CAROTENOIDS; DIET; FLAVONOIDS; HEALTH PROMOTION; HUMANS; LIVER; LIVER DISEASES; PHENOLS; QUERCETIN; STILBENES; VITAMIN A;

ANIMALIA; ROSMARINUS OFFICINALIS; THYMUS VULGARIS;

EID: 17444419030     PISSN: 10408398     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408690490911701     Document Type: Article

References (157)

1. Block G. 1992. The data support a role for antioxidants in reducing cancer risk. Nutrition Reviews, 50:207-213.
2. Block, G., Patterson, B., and Subar, A. 1992. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutrition and Cancer, 18:1-29.
3. Gillman, M.W., Cupples, A., and Cagnon, D. 1995. Protective effect of fruits and vegetables on development of stroke in men. Journal of the American Medical Association, 273:1114-1117.
4. Loguercio, C., De Girolamo, V, De Sio, I., Tuccillo, C., Ascione, A., Baldi, F., and Budillon, G. 2001. Non-alcoholic fatty liver disease in an area of southern Italy: Main clinical, histological and pathophysiological aspects. J. Hepatol., 35:568-574.
5. Parola, M. and Robino, G. 2001. Oxidative stress-related molecules and liver fibrosis. J. Hepatol., 35(2):297-306.
6. Tilg, H. and Diehl, A.M. 2000. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med., 343(20): 1467-1476.
7. Friedman, S.L. 1993. The cellular basis of hepatic fibrosis. N. Engt. J. Med., 328:1828-1835.
8. Kawada, N., Seki, S., Inoue, M., and Kuroki, T. 1998. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology, 27:1265-1274.
9. Pinzani, M. 1995. Novel insights into the biology and physiology of the Ito cell. Pharmacol. Ther., 66:387-412.
10. Gressner, A.M. 1995. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J. Hepatol., 22(suppl 2):28-36.
11. Ramadori, G. 1991. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver, New insights into pathophysiology of an intriguing cell. Virchows Arch. B. Cell. Pathol., 61:147-158.
12. Casini, A., Ceni, E., Salzano, R., Milani, S., Schuppan, D., and Surrenti, C. 1994. Acetaldehyde regulates the gene expression of matrix metalloproteinase-1 and -2 in human fat-storing cells. Life Sci., 55:1311-1316.
13. Lee, K.S., Buck, M., Houglum, K., and Chojkier, M. 1995. Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest., 96:2461-2468.
14. Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., and Pagano, G. 2003. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology, 37:909-916.
15. Froemming, G.R. andO'Brien, N.M. 1997. U937 cells as a model to study the effect of phytochemicals on Superoxide anion production. Nutr. Res., 17:1091-1103.
16. Noroozi, M., Angerson, W.J., and Lean, M.E.J. 1998. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr., 67:1210-1218.
17. Youdim, K.A., Martin, A., and Joseph, J.A. 2000. Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Rad. Biol. Med., 29:51-60.
18. Schroeter, H., Spencer, J.P.E., Rice-Evans, C., and Williams, R.J. 2001. Flavonoids protect neurons from oxidized low-density-lipoprotein induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem. J., 358:547-557.
19. Alfa, M., Horcajo, C., Bravo, L., and Goya, L. 2003. Effect of grape antioxidant dietary fiber on the total antioxidant capacity and the activity of liver antioxidant enzymes in rats. Nutrition Research, 23:1251-1267.
20. Cai, Q., Rahn, R., and Zhang, R. 1997. Dietary flavonoids, quercetin, luteolin, and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Letters, 119:99-107.
21. Bagchi, D., Garg, A., Krohn, R.L., Bagchi, M., Bagchi, D.J., Balmoori, J., and Stohs, S.J. 1998. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen. Pharmacol., 30:771-776.
22. Bagchi, M., Milnes, M., Williams, C., Balmoori, J., Ye, X., Stohs, S., and Bagchi, D. 1999. Acute and chronic stress-induced oxidative gastrointestinal injury in rats, and the protective ability of a novel grape seed proanthocyanidin extract. Nutr. Res., 19:1189-1199.
23. Breinholt, V., Lauridsen, ST., and Dragsted, L.O. 1999. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica, 29:1227-1240.
24. Pataki, T., Bak, I., Kovacs, P., Bagchi, D., Das, D.K., and Tosaki, A. 2002. Grape seed proanthocyanidins improve cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am. J. Clin, Nutr., 75:894-899.
25. Duthie, G.G., Duthie, S.J., and Kyle, J.A.M. 2000. Plant polyphenols in cancer and heart disease: Implications as nutritional antioxidants. Nutr. Res. Rev., 13:79-106.
26. Hininger, I., Chopra, M., Thurnham, D.I., Laporte, F., Richard, M.J., Favier, A., and Roussel, A.M. 1997. Effect of increased fruit and vegetable intake on the susceptibility of lipoprotein to oxidation in smokers. Eur. J. Clin. Nutr., 51:601-606.
27. Young, J.F., Dragsted, L.O., Daneshvar, B., Lauridsen, S.T., Hansen, M., and Sandstrom, B. 2000. The effect of grape-skin extract on oxidative status. Br. J. Nutr., 84:505-513.
28. Cao, G., Russell, R.M., Lischner, N., and Prior, R.L. 1998. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J. Nutr., 128:2383-2390.
29. Abu-Amsha Caccetta, R., Burke, V, Mori, T.A., Beilin, L.J., Puddey, I.E., and Croft, K.D. 2001. Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects. Free Rad. Biol. Med., 30:636-642.
30. Natella, F., Ghiselli, A., Guidi, A., Ursini, F., and Scaccini, C. 2001. Red wine mitigates the postprandial increase of LDL susceptibility to oxidation. Free Rod. Biol. Med., 30:1036-1044.
31. Jovanovic, S.V., Steenken, S., Simic, M.G., and Hara, Y. 1998. Antioxidant properties of flavonoids reduction potentials and electron transfer reactions of flavonoid radicals. In: Flavonoids in Health and Disease. Rice Evans, C., Packer, L. ed. pp. 137-161. New York: Marcel Dekker.
32. Peres, W., Tuñón, M. J., Collado, P. S., Herrmann, S., Marroni, N., and Gonzalez-Gallego, J. 2000. The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. Journal of Hepatology, 33:742-750.
33. Day, A.J., Canada, F.J., Diaz, J.C., Kroon, P.A., McLauchlan, R., Faulds, C.B., Plumb, G.W., Morgan, M.R., and Williamson, G. 2000. Dietary flavonoid and isoflavone glycosides are hydrolyzed by the lactase site of lactase phlorizin hydrolase. FEBS. Lett., 468:166-170.
34. Paganga, G., and Rice-Evans, C.A. 1997. The identification of flavonoids as glycosides in human plasma. FEBS. Lett., 401:78-82.
35. Aziz, A.A., Edwards, C.A., Lean, M.E., and Crozier, A. 1998. Absorption and excretion of conjugated flavonols, including quercetin-4′-O-β-glucoside and isorhamnetin-4′-O-β-glucoside by human volunteers after the consumption of onions. Free Radical Res., 29:257-269.
36. Meng, X., Maliakal, P., Hong, L., Lee, M.J., and Yang, C.S. 2004. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem., 52:935-942.
37. Huk, I., Brovkovich, V, Nanobash, V., Weigel, G., Neumayer, C., and Partyka, L. 1998. Bioflavonoid quercetin scavenges Superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury an experimental study. Br. J. Surg., 85:1080-1085.
38. Choi, E.J., Chee, K.M., and Lee, B.H. 2003. Anti- and prooxidant effects of chronic quercetin administration in rats. European Journal of Pharmacology, 482:281-285.
39. Sahu, S.C. and Gray, G.C. 1996. Pro-oxidant activity of flavonoids: Effects on glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer Lett., 104:193-196.
40. Van Acker, F.A., Schouten, O., Haenen, G.R., Van der Vijgh, W.J., and Bast, A. 2000. Flavonoids can replace alpha-tocopherol as an anti-oxidant. FEBS. Lett., 473:145-148.
41. Pedrielli, P. and Skibsted, L.H. 2002. Anti-oxidant synergy and regeneration effect of quercetin, (-)-epicatechin, and (+)-catechin on alpha-tocopherol in homogeneous solutions of peroxidating methyl linoleate. J. Agric. Food Chem., 50:7138-7144.
42. Asensi, M., Medina, I., Ortega, A., Carretero, J., BaÚo, M.C., Obrador, E., and Estrela, J.M. 2002. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radical Biology & Medicine, 33(3):387-398.
43. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sciences, 72:2219-2233.
44. Goldberg, D.M., Yan, J., and Soleas, G.J. 2003. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical Biochemistry, 36:79-87.
45. Friedman, S.L. 1993. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med., 328:1828-1835.
46. Desmoulière, A., Darby, I., Costa, A.M.A., Raccurt, M., Tuchweber, B., Sommer, P., and Gabbiani, G. 1997. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab, Invest., 76:765-778.
47. Milani, S., Herbst, H., Schuppan, D., Surrenti, C., Riecken, E.O., and Stein, H. 1990. Cellular localization of type I, III, and IV procollagen gene transcripts in normal and fibrotic human liver. Am. J. Pathol., 137: 59-70.
48. Neaud, V, Faouzi, S., Guirouilh, J., Le Bail, B., Balabaud, C., BioulacSage, P., and Rosenbaum, J. 1997. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor. Hepatology, 26:1458-1466.
49. Monvoisin, A., Neaud, V, De Ledinghen, V., Dubuisson, L., Balabaud, C., Bioulac-Sage, P., and Desmouliére, A. 1999. Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J. Hepatol., 30:511-518.
50. Godichaud, S., Krisa, S., Couronné, B., Dubuisson, L., Mérillon, J.-M., Desmoulière, A., and Rosenbaum, J. 2000. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology, 31:922-931.
51. Pendurthi, U.R. and Rao, L.V.M. 2002. Effect of wine phenolics and stilbene analogues on tissue factor expression in endothelial cells. Thrombosis Research, 106:205-211.
52. Weider, T., Prokop, A., Bagci, B., Essman, F., Bernicke, D., and Schulze-Osthoff, K. 2001. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lympoblasts. Leukemia, 15:1735-1742.
53. Fauconneau, B., Waffo-Teguo, P., Huguet, F., Barrier, L., Decendit, A., and Merillon, J.M. 1997. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinefera cell cultures using in vitro tests. Life Sci., 61:2103-2110.
54. Stivala,L.A., Savio,M.,Carafoli,F., Perucca,P., Blanchi, L., and Maga, G. 2001. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem., 276:22586-22594.
55. Juan, M., Lamuela-Raventos, R.M., De la Torre-Boronat, M.C., and Planas J.M. 1999. Determination of trans-resveratrol in plasma by HPLC. Anal. Chem., 71:747-750.
56. Bertelli, A.A.E., Giovannini, L., Stradi, R., Bertelli, A., and Tillement, J.P. 1996. Plasma, urine and tissue levels of trans and cis-resveratrol (3,48,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tiss. React., 18:67-71.
57. Bath, K.P., Kosmeder, J.Mn., and Pezzuto, J.M. 2001. Biological effects of rescveratrol. Antioxid Redox Signal, 3:1041-1064.
58. Jang, M., Cai, L., Udeani, G.O., Slowing K.V, Thomas, C.F., and Beecher, C.W. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275:218-220.
59. Ciolino, H.P. and Yeh, G.C. 2001. The effects of resveratrol on CYPIAI expression and aryl hydrocarbon receptor function in vitro. Adv. Exp. Med. Biol., 492:183-193.
60. Mutoh, M., Takahashi, M., Fukuda, K., Matsushima Hibiya, Y., Mutoh, H., and Sugimura, T. 2000. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis, 21:959-963.
61. Subbaramaiah, K., Chung, W.J., Michaluart, P., Telang, N., Tanabe, T., and Inoue, H. 1998. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273:21875-21882.
62. Roemer, K. and Mahyar-Roemer, M. 2002. The basis for the chemopreventive action of resveratrol. Drugs Today (Barc)., 38(8):571-580.
63. Bertelli, A.A.E., Giovannini, L., Stradi, R., Urien, S., Tillement, J.-P., and Bertelli, A. 1998. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp. Clin. Res., 24:51-55.
64. Bertelli, A., Bertelli, A.A.E., Gozzini, A., and Giovannini, L. 1998. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res., 24:133-138.
65. Dercks, W., and Creasy, L.L. 1989. Influence of fosetyl-Al on phytoalexin accumulation in the Plasmopara viticola-grapevine interaction. Physiol. Mol. Plant Pathol., 34:203-213.
66. Goldberg, D.M., Yan, J., Ng, E., Diamandis, E.P., Karumanchiri, A., and Soleas, G. 1995. A global survey of trans-resveratrol concentrations in commercial wines. Am. J. Enol. Vitic., 46:159-165.
67. Romeroperez, A.I., Lamuelaraventos, R.M., Waterhouse, A.L., and Delatorreboronat, M.C. 1996. Levels of cis- and rrans-resveratrol and their glucosides in white and rose Vitius vinifera wines from Spain. J. Agric. Food Chem., 44:2124-2128.
68. Flora, K., Hahn, M., Rosen, H., and Benner, K. 1998. Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol., 93:139-143.
69. Škottová, N., VeËea, R., Urbánek, K., VáÚa, P., Walterová, D., and Cvak, L. 2003. Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacological Research, 47:17-26.
70. Mira, L., Silva, M., and Manso, C.F. 1994. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem. Pharmacol., 48:753-759.
71. Bosisio, E., Benelli, C., and Pirola, O. 1992. Effect of the flavonolignans of Silybum marainum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacolog. Res., 25:147-154.
72. Carini, R., Comoglio, A., Albano, E., and Poli, G. 1992. Lipid peroxidation and irreversible damage in the rat hepatocyte model: Protection by the silybin-phospholipid complex IdB 1016. Biochem. Pharmacol., 43:2111-2115.
73. Boigk, G., Stroedter, L., Herbst, H., Waldschmidt, J., Riecken, E.O., and Schuppan, D. 1997. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology, 26:643-649.
74. Farghali, H., Kamenikova, L., Hynie, S., and Kmonickova, E. 2000. Silymarin effects on intracellular calcium and cytotoxicity: A study in perfused rat hepatocytes after oxidative stress injury. Pharmacological Research, 41(2):231-237.
75. 2+ and cytotoxicity in rat hepatocytes. J. Biol. Chem., 267: 6654-6663.
76. Valenzuela, A., and Garrido, A. 1994. Biochemical bases of the pharmacological action of the flavonoid silymarin and its structural isomer silibinin. Biol. Res., 27:105-112.
77. Campos, R., Garrido, A., Guerra, R., and Valenzuela, A. 1989. Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver. Planta. Med., 55:417-419.
78. KreËman, V., Škottová, N., Walterová, D., Ulrichová, J., and Šimánek, V. 1998. Silymarin inhibits the development of diet-induced hypercholesterolemia in rats. Planta. Med., 64:138-142.
79. Saller, R., Meier, R., and Brignoli, R. 2001. The use of silymarin in the treatment of liver diseases. Drugs, 61:2035-2063.
80. Wellington, K. and Jarvis, B. 2001. Silymarin: A review of its clinical properties in the management of hepatic disorders. BioDrugs, 15:465-489.
81. Parés, A., Planas, R., Torres, M., Caballeria, J., Viver, J.M., Acero, D., Panés, J., Rigau, J., Santos, J., and Rodes, J. 1998. Effects of sylimarin in alcoholic patients with cirrhosis of the liver: Results of a controlled, double-blind, randomized and multicenter trial. Journal of Hepatology, 28:615-621.
82. Morazzoni, P., and Bombardelli, E. 1995. Silybum marianum (Carduus marianus). Fitoterapia, 66:3-42.
83. Basaga, H., Poli, G., Tekkaya, C., and Aras, I. 1997. Free radical scavenging and antioxidative properties of "silibin" complexes on microsomal lipid peroxidation. Cell Biochem. Funct., 15:27-33.
84. Škottová, N., KreËman, V., VáÚa, P., Chmela, Z., Ulrichová, J., and Šimánek, V. 2000. Effect of silymarin and silibinin-phosphatidylcholine complex on plasma and lipoprotein cholesterol, and oxidation of LDL in rats fed on high cholesterol diet supplemented with currant oil. Acta Univ. Palacki. Olomuc. Fac. Med., 144:55-58.
85. Duke, J. A. 1992. Handbook of phytochemical constituents of GRAS herbs and other economic plants. London: CRC Press, 160-161.
86. Chang, W.S., Chang, Y.H., Lu, F.J., and Chiang, H.C. 1994. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res., 14:501-506.
87. Tubaro, A., Negro, P.D., Ragazzi, E., Zampiron, S., and Loggia, R.D. 1988. Anti-inflammatory and peripheral analgesic activity of esculetin in vivo. Pharmacol. Res. Commun., 20:83-85.
88. Loggia, R.D., Raggazi, E., Tubaro, A., Fassina, G., and Vertua, R. 1988. Anti-inflammatory activity of benzopyrone that are inhibitors of cycloand lipoxygenase. Pharmacol. Res. Commun., 20:91-94.
89. Noguchi, M., Kitagawa, H., Miyazaki, I., and Mizukami, Y. 1993. The influence of esculetin on incidence, proliferation, and cell kinetics of mammary carcinoma in induced by 7,12 dimethylbenzo[a]anthracene in rats on high- and low-fat diet. Jpn. J. Cancer Res., 84:1010-1014.
90. Kitagawa, H. and Noguchi, M. 1994. Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinoma induced by 7,12 dimethylbenzo[a]anthracene in rats on high-and low-fat diets. Oncology, 51:401-410.
91. Riedel, A., and Mest, H.J. 1987. The effect of PAF platelet-activating factor on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites. Prostaglandins Leukot. Med., 28:103-109.
92. Hata, S., Sugama, K., You, L.Z., Hatanaka, M., Namba, Y, and Hanaoka, M. 1987. Synthesis of sterols and 5-lipoxygenase products are required for the G1-S phase transition of interlukin-2-dependent lymphocyte proliferation. Microbiol. Immunol., 31:1231-1244.
93. Solano, A.R., Dada, L., and Podesta, E.J. 1988. Lipoxygenase products as common intermediate in cyclic-AMP-dependent and independent adrenal steroidogenesis in rats. J. Mol. Endocrinol., 1:147-154.
94. Kimura, Y., Okuda, H., Arichi, S., Baba, K., and Kozawa, M. 1985. Inhibition of the formation of 5-hydroxy-6, 8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. Biochim. Biophys. Acta, 834:224-229.
95. De-Clerck, F. and Xhonneux, B. 1986. Effect of ketanserin, a selective 5-HT serotonergic antagonist, on the secondary recruitment of human platelets in vitro. Agents Actions, 17:515-526.
96. Simmet, T., Aissa, J., Sutter, D., Juan, H., and Peskar, B.A. 1987. Modulation of the contractile activity of the guineapig lung parenchymal strip by exogenous 5, 8, 11, 14, 17-eicosapentaenoic acid. Naunyn-Schmiedebergs Arch. Pharmacol., 335:552-659.
97. Neichi, T., Koshihara, Y, and Murota, S. 1983. Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim. Biophys.Acta, 753:130-132.
98. Panossian, A.C. 1984. Inhibition of arachidonic acid 5-lipoxygenase of human polymorphonuclear leukocytes by esculetin. Biomed. Biochem. Acta, 43:351-355.
99. Leung, K.H. and Ip, M.M. 1986. Regulation of rat natural killing. II. Inhibition of cytolysis and activation of inhibitors of lipoxygenase: Possible role of leukotrienes. Cell Immunol., 100:474-484.
100. Morita, I., Takahashi, R., Saito, Y., and Murota, S. 1983. Stimulation of eicosapentaenoic acid metabolism in washed human platelets by 12-hydroperoxyeicosatetraenoic acid. J. Biol. Chem., 258:10197-10199.
101. Veser, J. 1987. Kinetics and inhibition studies of catecholo-methyl transferase from the yest. Candida tropicalis, J Bacteriol., 169:3696-3700.
102. Ozaki, Y., Ohashi, T., and Niwa, Y 1986. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. Biochem. Pharmacol., 35:3481-3488.
103. 4. Pharmacological Research, 37:31-35.
104. Kawamori, T., Lubet, R., Steele, V. E., Kellof, G. J., Kaskey, R. B., Rao, C. V., and Reddy, B. S. 1999. Chemopreventative effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res., 59:597-601.
105. Jovanovic, S. V., Steenken, S., Boone, C. W., and Simic, M. G. 1999. H-atom transfer is a preferred antioxidant mechanism of curcumin. J. Am. Chem. Soc., 121:9677-9681
106. Morikawa, T., Matsuda, H., Ninomiya, K., and Yoshikawa, M. 2002. Medicinal foodstuffs. XXIX. Potent protective effects of sesquiterpenes and curcumin from Zedoariae Rhizoma on liver injury induced by D-galactosamine/lipopolysaccharide or tumor necrosis factor-alpha. Biol. Pharm. Bull., 25:621-31.
107. Sharma, R.A., Ireson, C.R., Verschoyle, R.D., Hill, K.A., Williams, M.L., Leuratti, C., Manson, M.M., Marnett, L.J., Steward, W.P., and Gescher, A. 2001. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels. Clin. Cancer Res., 7:1452-1458.
108. Kempaiah, R.K. and Srinivasan, K. 2004. Influence of Dietary Curcumin, Capsaicin and Garlic on the Antioxidant Status of Red Blood Cells and the Liver in High-Fat-Fed Rats. Ann. Nutr. Metab., 48:314-320.
109. Naik, R.S., Mujumdar, A.M., and Ghaskadbi, S. 2004. Protection of liver cells from ethanol cytotoxicity by curcumin in liver slice culture in vitro. J. Ethnopharmacol., 95:31-37.
110. Youdim, K.A. and Deans, S.G. 1999. Dietary supplementation of thyme (Thymus vulgaris L.) essential oil during theifetimo: Its effects on the antioxidant status in liver, kidney and heart tissues. Mechanisms of Ageing and Development, 109:163-175.
111. Sotelo-Félix, J.I.,Martinez-Fong, D., Muriel, P., Santillan, R.L., Castillo, D., and Yahuaca, P. 2002. Evaluation of the effectiveness of Rosmarinus officinalis (Lamiaceae) in e alleviation of carbon-tetrachloride-induced acute hepaooxi in the rat. Journal of Ethnopharmacology, 81:145-154.
112. Nagita, A. and Ando, M. 1997. Assesment of hepatic vitamin E in adult patients with liver disease. Hepatology, 26:392-397.
113. Okita, M., Tomioka, K., and Ota, Y 2003. Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients. Nutrition, 19:727-732.
114. Hill, D.B., Devalaraja, R., Joshi-Barve, S., Barve, S., and McClain, C.J. 1999. Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factoralpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro. Clin. Biochem., 32:563-570.
115. Lee, K.S., Buck, M., Houglum, K., and Chojkier, M. 1995. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest., 96:2461-2468.
116. Pietrangelo, A., Gualdi, R., Casalgrandi, G., Montosi, G., and Ventura E. 1995. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J. Clin. Invest., 95:1824-1831.
117. Parola, M., Leonarduzzi, G., and Biasi, F. 1992. Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology, 16:1014-1021.
118. Parola, M., Muraca, R., and Dianzani, I. 1992. Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEBS. Lett., 308:267-270.
119. Houglum, K., Venkataramani, A., Lyche, K., and Chojkier, M. 1997. A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology, 113:1069-1073.
120. Lavine, J.E. 2000. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study. J. Pediatr., 136:734-738.
121. Hasegawa, T., Yoneda, M., and Nakamura, K. 2001. Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: A pilot study. Aliment Pharmacol. Ther., 15:1667-1672.
122. Kugelmas, M., Hill, D.B., Vivian, B., Marsano, L., and McClain, C.J. 2003. Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E. Hepatology, 38(2):413-419.
123. Davi, G., Guagnano, M.T., Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., and Nutini, M. 2002. Platelet activation in obese women: Role of inflammation and oxidant stress. JAMA, 288:2008-2014.
124. Von Herbay, A., Stahl, W., Niederau, C., and Sies, H. 1997. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: A randomized, double-blind, placebo-controlled study. Free Radic. Res., 27:599-605.
125. 2α in rats. J. Nutr., 130:10-14.
126. Pratico, D., Iuliano, L., Basili, S., Ferro, D., Camastra, C., Cordova, C., FitzGerald, G.A., and Violi, F. 1998. Enhanced lipid peroxidation in hepatic cirrhosis. J. Investig Med., 46:51-57.
127. Ota, Y., Sasagawa, T., Suzuki, K., Tomioka, K., Nagai, A., Niiyama, G., Kawanaka, M., Yamada, G., and Okita, M. 2004. Vitamin E Supplementation. Increases Polyunsaturated Fatty Acids of RBC Membrane in HCV-Infected Patients. Nutrition, 20:358-363.
128. Takagi, H., Kakizaki, S., Sohara, N., Sato, K., Tsukioka, G., Tago, Y., Konaka, K., Kabeya, K., Kaneko, M., Takayama, H., Hashimoto, Y., Yamada, T., Takahashi, H., Shimojo, H., Nagamine, T., and Mori, M. 2003. Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis. Int. J. Vitam. Nutr. Res., 73(6):411-415.
129. Dimitrov, N.V., Meyer, C., and Ullrey, D.E. 1988. Bioavailability of β-carotene in humans. Am. J. Clin. Nutr., 48:298-304.
130. Rock, C.L. and Swendseid, M.E. 1992. Plasma β-carotene response in humans after meals supplemented with dietary pectin. Am. J. Clin, Nutr., 55:96-99.
131. Martucci, R.B., Ziulkoski, A.L., Fortuna, VA., Guaragna, R.M., Guma, F.C., Trugo, L.C., and Borojevic, R. 2004. Beta-carotene storage, conversion to retinoic acid, and induction of the lipocyte phenotype in hepatic stellate cells. J. Cell Biochem., 92(2):414-23.
132. Munoz, S.J., Heubi, J.E., Balisteri, W.F., and Maddrey, W.C. 1989. Vitamin E deficiency in primary biliary cirrhosis: Gastrointestinal malabsorption, frequency and relationship to other lipid-soluble vitamins. Hepatology, 9:525-531.
133. Rocchi, E., Borghi, A., Paolillo, F., Pradelli, M., and Casalgrandi, G. 1991. Carotenoids and liposoluble vitamins in liver cirrhosis. J. Lab. Clin. Med., 118:176-185.
134. Leo, M.A., Kim, C.I., and Lowe, N. 1992. Interaction of ethanol with α-carotene: Delayed blood clearanceand enhanced hepatotoxicity. Hepatology, 15:883-891.
135. Von Herbay, A., De Groot, H., Hegi, U., Stremmel, W., Strohmeyer, G., and Sies, H. 1994. Low vitamin E content in plasma of patients with alcoholic liver disease, haemochromatosis and Wilson's disease. J. Hepatol., 20:41-46.
136. Rocchi, E., Casalgrandi, G., Ronzoni, A., Rosa, M.C., Cioni, G., Marazzi, A., Manenti, A., Marchini, S., and Ventura, E. 2001. Antioxidant liposolible vitamins and carotenoids in chronic hepatitis. European Joral. of Internal Medicine, 12:116-121.
137. Blomhoff, R., Green, M.H., Green, J.B., Berg, T., and Norum, K.R. 1991. Vitamin A metabolism: New perspectives on absorption, transport and storage. Physiol. Rev., 71:951-990.
138. Moriya, K., Fujie, H., Shintani, Y, Yotsuyanaga, H., Tsutsumi, T., and Ishibashi, K. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med., 4:1065-1067.
139. Yotsuyanagi, H., Moriya, K., Shintani, Y., Tsutsumi, T., Takayama, T., and Makuuchi, M. 1999. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J. Med. Virol., 59:141-145.
140. Subirade, I., Fernandez, Y., Periquet, B., Mitjavila, S., Anglada, F., and Periquet, A. 1996. Plasma and hepatic antioxidant control and vitamin A nutritional status. Experientia, 15:687-690.
141. 4-induced hepatic inflammation and fibrosis in rats. Liver, 15(1):1-8.
142. Wardi, J., Reifen, R., Aeed, H., Zadel, L., Avni, Y, and Bruck, R. 2001. Beta-carotene attenuates experimentally induced liver cirrhosis in rats. Isr. Med. Assoc. J., 3(2): 151-154.
143. Gumpricht, E., Dahl, R., Devereaux, M.W., and Sokol, R.J. 2004. Betacarotene prevents bile acid-induced cytotoxicity in the rat hepatocyte: Evidence for an antioxidant and anti-apoptotic role of beta-carotene in vitro. Pediatr. Res., 55(5):814-821.
144. Alija, A.J., Bresgen, N., Sommerburg, O., Siems, W., and Eckl, P.M. 2004. Cytotoxic and genotoxic effects of beta-carotene breakdown products on primary rat hepatocytes. Carcinogenesis, 25(5):827-831.
145. Stahl, W. and Sies, H. 1992. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice. J. Nutr., 122:2161-2166.
146. Gärtner, C., Stahl, W., and Sies, H. 1997. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am. J. Clin. Nutr., 66:116-122.
147. Khachik, F., Carvalho, L., Bernstein, P.S., Muir, G.J., Zhao, D.Y., and Katz, N.B. 2002. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp. Biol. Med., 227(10):845-851.
148. Pan, H., Shi, G., Chen, W., and Wang, D. 2003. Effect of lycopene on the function of antioxidative enzyme system in rats. Wei. Sheng. Yan. Jiu., 32(5):441-442.
149. Kravchenko, L.V., Morozov, S.V., Beketova, N.A., Deryagina, V.P., Avren'eva, L.I., and Tutel'yan, V.A. 2003. Antioxidant status of rats receiving lycopene in different doses. Bull. Exp. Biol. Med., 135(4):353-357.
150. Xu, Y, Leo, M.A., and Lieber, C.S. 2003. Lycopene attenuates alcoholic apoptosis in HepG2 cells expressing CYP2E1. Biochem. Biophys. Res. Commun., 308(3):614-618.
151. Diwadkar-Navsariwala, V, Novotny, J.A., Gustin, D.M., Sosman, J.A., Rodvold, K.A., Crowell, J.A., Stacewicz-Sapuntzakis, M., and Bowen, P.E. 2003. A physiological pharmacokinetic model describing the disposition of lycopene in healthy men. J. Lipid. Res., 44(10): 1927-1939.
152. Cohen, L.A. 2002. A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp. Biol. Med., 227(10):864-868.
153. 14C]-labeled polar products are differentially distributed in tissues of F344 rats prefed lycopene. J. Nutr., 133(12):4189-4195.
154. Floreani, A., Baragiotta, A., Martines, D., Naccarato, and R., D'odorico, A. 2000. Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment. Pharmacol. Ther., 14(3):353-358.
155. Yadav, D., Hertan, H.I., Schweitzer, P., Norkus, E.P., and Pitchumoni, C.S. 2002. Serum and liver micronutrient antioxidants and serum ox idative stress in patients with chronic hepatitis C. Am. J. Gastroenterol, 97(10):2634-2639.
156. Morisco, F., Vitaglione, P., Carbone, A., Stingo, S., Scarpati, S., Marmo, R., Ascione, A., Fogliano, V., and Caporaso, N. 2004. Tomato functional foods as Interferon adjuvant in HCV eradication therapy. Journal of Clinical Gastroenterology, 38:118-120.
157. Urso, M.L. and Clarkson, P.M. 2003. Oxidative stress, exercise, and antioxidant supplementation Toxicology, 189:41-54.